Adrenocorticotropic Hormone(ACTH) & Related Peptides |
|
Product |
CAT# |
Sequence |
ACTH (1-10), human |
TYA019-010
TYA019-050 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly |
ACTH (1-13), human |
TYA020-005
TYA020-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val |
ACTH (1-16), human |
TYA021-005
TYA021-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys |
ACTH (1-17), human |
TYA022-005
TYA022-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg |
ACTH (1-24), human |
TYA023-005
TYA023-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
ACTH (18-39), human |
TYA024-005
TYA024-010 |
Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
ACTH (4-10), human |
TYA025-010
TYA025-050 |
Met-Glu-His-Phe-Arg-Trp-Gly |
ACTH (4-11), human |
TYA026-010
TYA026-050 |
Met-Glu-His-Phe-Arg-Trp-Gly-Lys |
ACTH (6-24), human |
TYA027-005
TYA027-010 |
His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
N-Acetyl, ACTH (1-17), human |
TYN001-005
TYN001-010 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg |
|
|
|
|
Product |
CAT# |
Sequence |
Adrenomedullin (1-12), human |
TYA033-005
TYA033-010 |
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg |
Adrenomedullin (22-52), human |
TYA034-001 |
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Pro-Adrenomedullin (153-185), human |
TYP056-001
TYP056-005 |
Ser-Leu-Pro-Glu-Ala-Gly-Pro-Gly-Arg-Thr-Leu-Val-Ser-Ser-Lys-Pro-Gln-Ala-His-Gly-Ala-Pro-Ala-Pro-Pro-Ser-Gly-Ser-Ala-Pro-His-Phe-Leu |
Pro-Adrenomedullin (N-20), porcine |
TYP057-005
TYP057-010 |
Ala-Arg-Leu-Asp-Val-Ala-Ala-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 |
Pro-Adrenomedullin N-20, rat |
TYP059-005 |
Ala-Arg-Leu-Asp-Thr-Ser-Ser-Gln-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 |
|
|
|
|
Product |
CAT# |
Sequence |
Allatostatin I |
TYA041-010
TYA041-050 |
Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2 |
Allatostatin II |
TYA042-010
TYA042-050 |
Gly-Asp-Gly-Arg-Leu-Tyr-Ala-Phe-Gly-Leu-NH2 |
Allatostatin III |
TYA043-010
TYA043-050 |
Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 |
Allatostatin IV |
TYA044-010
TYA044-050 |
Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 |
|
|
|
|
Product |
CAT# |
Sequence |
Amyloid 17-42 |
TYA048-001 |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
[Gln11] ¦Â-Amyloid (1-16) |
TYA050-005
TYA050-010 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys |
¦Â-Amyloid (1-11) |
TYA053-005 TYA053-010 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu |
¦Â-Amyloid (1-28) |
TYA054-005
TYA054-010 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
¦Â-Amyloid (10-20) |
TYA055-005
TYA055-010 |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe |
¦Â-Amyloid (12-28) |
TYA056-005
TYA056-010 |
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
¦Â-Amyloid (17-40) |
TYA057-005
TYA057-010 |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
¦Â-Amyloid (22-35) |
TYA058-005
TYA058-010 |
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
¦Â-Amyloid (25-35) |
TYA059-005
TYA059-010 |
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
¦Â-Amyloid (35-25) |
TYA062-005
TYA062-010 |
Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly |
¦Â-Amyloid / A4 Protein Precursor (APP) (96-110) |
TYA064-005
TYA064-010 |
Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 |
¦Â-Amyloid / A4 Protein
Precursor (APP) (319-335) |
TYA065-005
TYA065-010 |
Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met |
¦Â-Amyloid Precursor
Protein (657-676) |
TYA066-005
TYA066-010 |
His-His-Gly-Val-Val-Glu-Val-Asp-Ala-Ala-Val-Thr-Pro-Glu-Glu-Arg-His-Leu-Ser-Lys |
|
|
|
|
Product |
CAT# |
Sequence |
Angiogenin Fragment (108-122) |
TYA069-010 |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg |
Angiogenin Fragment (108-123) |
TYA070-010 |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro |
Angiotensin I, human |
TYA073-050 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu |
Apelin-13, human, bovine |
TYA102-005
TYA102-010 |
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe |
[Ala-Pro-Gly-(Ile3,Val5)] Angiotensin II |
TYA085-050 |
Ala-Pro-Gly-Asp-Arg-Ile-Tyr-Val-His-Pro-Phe |
[Asn1, Val5, Asn9]
Angiotensin I, salmon |
TYA078-050 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu |
[Asn1,Val5] Angiotensin II |
TYA086-050 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe |
[Ile7] Angiotensin III |
TYA090-050 |
Arg-Val-Tyr-Ile-His-Pro-Ile |
[Val4] Angiotensin III |
TYA091-050 |
Arg-Val-Tyr-Val-His-Pro-Phe |
[Val5] Angiotensin II, human |
TYA087-050 |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe |
|
|
Atrial Natriuretic Peptides |
|
Product |
CAT# |
Sequence |
Anantin |
TYA068-005
TYA068-010 |
Gly-Phe-Ile-Gly-Trp-Gly-Asn-Asp-Ile-Phe-Gly-His-Tyr-Ser-Gly-Asp-Phe |
ANP (1-11), rat |
TYA096-010 |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg |
Cardiodilatin (1-16), human |
TYC025-010
TYC025-050 |
Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys |
Prepro-ANF (104-116), human |
TYP038-005
TYP038-010 |
Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg |
Prepro-ANF (104-123), human |
TYP039-005
TYP039-010 |
Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg-Ala-Leu-Leu-Thr-Ala-Pro-Arg |
Prepro-ANF (26-55), human |
TYP040-005
TYP040-010 |
Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp |
|
|
|
|
Product |
CAT# |
Sequence |
| a-Bag Cell Peptide (1-7) |
TYB002-010 |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr |
| a-Bag Cell Peptide (1-8) |
TYB003-010 |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser |
| a-Bag Cell Peptide (1-9) |
TYB004-010 |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser-Leu |
| b-Bag Cell Factor |
TYB005-010 |
Arg-Leu-Arg-Phe-His |
| g-Bag Cell Factor |
TYB006-010 |
Arg-Leu-Arg-Phe-Asp |
|
|
|
|
Product |
CAT# |
Sequence |
| Bone Gla Protein (45-49) |
TYB028-010
TYB028-050 |
Phe-Tyr-Gly-Pro-Val |
| Myelopeptide¨C2 (MP-2) |
TYM046-005
TYM046-010 |
Leu-Val-Val-Tyr-Pro-Trp |
| Osteocalcin (37-49), human |
TYO006-010
TYO006-050 |
Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val |
| [Tyr38, Phe42,46] Bone Gla Protein (38-49), human |
TYB029-010 |
Tyr-Gln-Glu-Ala-Phe-Arg-Arg-Phe-Phe-Gly-Pro-Val |
|
|
|
|
Product |
CAT# |
Sequence |
Bradykinin |
TYB032-100 |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
Lys-(Des-Arg9, Leu8)-Bradykinin |
TYL038-050 |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu |
[Ile-Ser0]-Bradykinin |
TYB039-050 |
Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Lys0-Ala3] Bradykinin |
TYB040-050
TYB040-025 |
Lys-Arg-Pro-Ala-Gly-Phe-Ser-Pro-Phe-Arg |
[Lys0] Bradykinin |
TYB042-050
TYB042-250 |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Met-Lys0] Bradykinin |
TYB043-050
TYB043-250 |
Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Tyr0] Bradykinin |
TYB044-050 |
Tyr-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Tyr5] Bradykinin |
TYB045-050 |
Arg-Pro-Pro-Gly-Tyr-Ser-Pro-Phe-Arg |
[Tyr8] Bradykinin |
TYB046-050 |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg |
|
|
Calcitonin Gene Related Peptide |
|
Product |
CAT# |
Sequence |
Calcitonin C-terminal
Adjacent Peptide, rat |
TYC009-005
TYC009-010 |
Asp-Met-Ala-Lys-Asp-Leu-Glu-Thr-Asn-His-His-Pro-Tyr-Phe-Gly-Asn |
Calcitonin Gene Related
Peptide (20-37), human |
TYC011-005
TYC011-010 |
Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 |
Calcitonin Gene Related
Peptide (8-37), human |
TYC012-005
TYC012-010 |
Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 |
Calcitonin Gene Related
Peptide (8-37), rat |
TYC013-005
TYC013-010 |
Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 |
| Katacalcin |
TYC003-005
TYC003-010 |
Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn |
[Tyr0] Calcitonin Gene
Related Peptide (28-37), rat |
TYC014-005
TYC014-010 |
Tyr-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 |
[Tyr22] Calcitonin Gene
Related Peptide, (22-37), rat |
TYC015-005
TYC015-010 |
Tyr-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 |
|
|
|
|
Product |
CAT# |
Sequence |
| Cholecystokinin Flanking Peptide, Non sulfated |
TYC051-010 |
Ser-Ala-Glu-Glu-Tyr-Glu-Tyr-Pro-Ser |
| Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form |
TYC049-010
TYC049-050 |
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| Cholecystokinin, CCK (27-33) |
TYC048-010
TYC048-050 |
Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| Cholecystokinin, CCK Tetrapeptide (30-33) |
TYC050-010 |
Trp-Met-Asp-Phe-NH2 |
| N-Acetyl Cholecystokinin, CCK (26-31), non-sulfated |
TYN002-010
TYN002-050 |
Ac-Asp-Tyr-Met-Gly-Trp-Met-NH2 |
| Prepro CCK fragment V-9-M |
TYP041-010 |
Val-Pro-Val-Glu-Ala-Val-Asp-Pro-Met |
|
|
|
|
Product |
CAT# |
Sequence |
b-Casomorphin (1-6), bovine |
TYC033-010 |
Tyr-Pro-Phe-Pro-Gly-Pro |
| b-Casomorphin(1-7), bovine |
TYC034-050
TYC034-250 |
Tyr-Pro-Phe-Pro-Gly-Pro-Ile |
| b-Casomorphin, human |
TYC035-050
TYC035-250 |
Tyr-Pro-Phe-Val-Glu-Pro-Ile |
| [Des-Tyr1] b-Casomorphin, bovine |
TYC036-010
TYC036-050 |
Pro-Phe-Pro-Gly-Pro-Ile |
| ¦Â-Casomorphin (1-5), amide, bovine |
TYC039-010 |
Tyr-Pro-Phe-Pro-Gly-NH2 |
| ¦Â-Casomorphin (1-5), bovine |
TYC040-010 |
Tyr-Pro-Phe-Pro-Gly |
|
|
Dynorphins |
|
Product |
CAT# |
Sequence |
Dynorphin (2-17), amide, porcine |
TYD010-010 |
Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 |
Dynorphin A (1-17) |
TYD011-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln |
Dynorphin A amide, porcine |
TYD012-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 |
Dynorphin B (1-9) |
TYD016-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe |
Prodynorphin (228-240), porcine |
TYP048-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr |
Prodynorphin (228-256), porcine |
TYP049-005
TYP049-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-Arg-Ser-Gln-Glu-Asp-Pro-Asn-Ala-Tyr-Tyr-Glu-Glu-Leu-Phe-Asp-Val |
| [Des-Tyr1] Dynorphin A (1-8) |
TYD015-010 |
Gly-Gly-Phe-Leu-Arg-Arg-Ile |
| [Phe7] Dynorphin A (1-7), amide, porcine |
TYD013-005
TYD013-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Phe-NH2 |
| [Phe7] Dynorphin A (1-7), porcine |
TYD014-005
TYD014-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Phe |
|
|
|
|
Product |
CAT# |
Sequence |
Adrenorphin, Free Acid |
TYA036-010
TYA036-050 |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val |
Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met |
TYA039-010
TYA039-050 |
Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met |
Leu-Enkephalin, amide |
TYL015-050 |
Tyr-Gly-Gly-Phe-Leu-NH2 |
Leu-Enkephalin |
TYL016-250 |
Tyr-Gly-Gly-Phe-Leu |
Met-Enkephalin |
TYM022-050 |
Tyr-Gly-Gly-Phe-Met |
Met-Enkephalin, amide |
TYM023-100 |
Tyr-Gly-Gly-Phe-Met-NH2 |
Preproenkephalin B (186-204), human |
TYP051-010 |
Ser-Ser-Glu-Val-Ala-Gly-Glu-Gly-Asp-Gly-Asp-Ser-Met-Gly-His-Glu-Asp-Leu-Tyr |
Spinorphin, bovine |
TYS033-010 |
Leu-Val-Val-Tyr-Pro-Trp-Thr |
[Ala2] Met-Enkephalin, amide |
TYM024-050 |
Tyr-Ala-Gly-Phe-Met-NH2 |
| [Arg0] Met-Enkephalin |
TYM025-010 TYM026-050 |
Arg-Tyr-Gly-Gly-Phe-Met |
|
|
|
|
Product |
CAT# |
Sequence |
a-Endorphin |
TYE010-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr |
a-Neo-Endorphin (1-7) |
TYN006-010
TYN006-050 |
Tyr-Gly-Gly-Phe-Leu-Arg-Lys |
a-Neo-Endorphin Analog |
TYN007-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Arg-Pro-Lys-NH2 |
a-Neo-Endorphin, porcine |
TYN008-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys |
Ac, a-Endorphin |
TYA010-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr |
Ac, b-Endorphin (1-27), camel, bovine, ovine |
TYA011-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His |
Ac, g-Endorphin |
TYA012-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr- Leu |
Acetyl, b-Endorphin (1-26), human |
TYA006-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala |
Acetyl, b-Endorphin (1-27), human |
TYA007-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr |
b-Endorphin (1-26), human |
TYE011-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala |
| b-Endorphin (1-27), camel, bovine, ovine |
TYE012-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His |
| b-Endorphin (1-27), human |
TYE013-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr |
| b-Endorphin (1-5) + (16-31), human |
TYE014-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu |
|
|
Fibronectin & Extra Cellular Matrix Related Peptides |
|
Product |
CAT# |
Sequence |
Fibrinopeptide A, human |
TYF006-010
TYF006-050 |
Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg |
| Fibronectin Analog |
TYF001-010 |
Gly-Arg-Ala-Asp-Ser-Pro-Lys |
| Fibronectin CS1 Peptide |
TYF011-010
TYF011-050 |
Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr |
| G-R-A-D-S-P |
TYG032-010 |
Gly-Arg-Ala-Asp-Ser-Pro |
| G-R-G-D-N-P |
TYG034-010 |
Gly-Arg-Gly-Asp-Asn-Pro |
| G-R-G-D-S |
TYG035-010
TYG035-050 |
Gly-Arg-Gly-Asp-Ser |
| G-R-G-D-S-P |
TYG036-010 |
Gly-Arg-Gly-Asp-Ser-Pro |
|
|
Glucagon & Related Peptides |
|
Product |
CAT# |
Sequence |
Glucagon (19-29), human |
TYG017-010
TYG017-050 |
Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
Glucagon (22-29), human |
TYG018-010 |
Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
Glucagon, human |
TYG016-005
TYG016-010 |
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
Glucagon-like Peptide I (7-36), amide, human |
TYG021-005
TYG021-010 |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 |
Valosin Peptide (VQY), porcine |
TYV003-010 |
Val-Gln-Tyr-Pro-Val-Glu-His-Pro-Asp-Lys-Phe-Leu-Lys-Phe-Gly-Met-Thr-Pro-Ser-Lys-Gly-Val-Leu-Phe-Tyr |
[Des-His1,Glu9] Glucagon |
TYG019-005
TYG019-010 |
Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
[Des-His1,Glu9] Glucagon, amide |
TYG020-005
TYG020-010 |
Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr ¨CNH2 |
|
|
|
|
Product |
CAT# |
Sequence |
Brain Derived Acidic Fibroblast Growth Factor (1-11) |
TYB047-010 |
Phe-Asn-Leu-Pro-Leu-Gly-Asn-Tyr-Lys-Lys-Pro |
Brain Derived Acidic Fibroblast Growth Factor (102-111) |
TYB049-010 |
His-Ala-Glu-Lys-His-Trp-Phe-Val-Gly-Leu |
| Brain Derived Basic Fibroblast Growth Factor (1-24) |
TYB048-005
TYB048-010 |
Pro-Ala-Leu-Pro-Glu-Asp-Gly-Gly-Ser-Gly-Ala-Phe-Pro-Pro-Gly-His-Phe-Lys-Asp-Pro-Lys-Arg-Leu-Tyr |
| Epidermal Growth Factor Receptor Peptide (985-996) |
TYE035-010 |
Asp-Val-Val-Asp-Ala-Asp-Glu-Tyr-Leu-Ile-Pro-Gln |
| Insulin-like Growth Factor I (24-41) |
TYI005-010 |
Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr |
| Insulin-like Growth Factor I (30-41) |
TYI006-010 |
Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr |
| Insulin-like Growth Factor II (69-84) |
TYI009-010 |
Asp-Val-Ser-Thr-Pro-Pro-Thr-Val-Leu-Pro-Asp-Asn-Phe-Pro-Arg-Tyr |
| Insulin-like Growth [Tyr0] Factor II (33-40) |
TYI010-010 |
Tyr-Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg |
|
|
|
|
Product |
CAT# |
Sequence |
Leucokinin I |
TYL007-010 |
Asp-Pro-Ala-Phe-Asn-Ser-Trp-Gly-NH2 |
Leucokinin II |
TYL008-010 |
Asp-Pro-Gly-Phe-Ser-Ser-Trp-Gly-NH2 |
Leucokinin III |
TYL009-010 |
Asp-Gln-Gly-Phe-Asn-Ser-Trp-Gly-NH2 |
Leucokinin IV |
TYL010-010 |
Asp-Ala-Ser-Phe-His-Ser-Trp-Gly-NH2 |
Leucokinin V |
TYL011-010 |
Gly-Ser-Gly-Phe-Ser-Ser-Trp-Gly-NH2 |
Leucokinin VII |
TYL012-010 |
Asp-Pro-Ala-Phe-Ser-Ser-Trp-Gly-NH2 |
Leucokinin VIII |
TYL013-010 |
Gly-Ala-Ser-Phe-Tyr-Ser-Trp-Gly-NH2 |
Leucopyrokinin (LPK) |
TYL014-010 |
Glp-Thr-Ser-Phe-Thr-Pro-Arg-Leu-NH2 |
|
|
Melanocyte Stimulating Hormones(MSH) |
|
Product |
CAT# |
Sequence |
a-MSH, amide |
TYM033-010
TYM033-050 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
a-MSH, Free Acid |
TYM037-010 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val |
b-MSH, human |
TYM038-010 |
Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp |
b-MSH, porcine |
TYM039-010 |
Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp |
g-1-MSH, amide |
TYM041-010 |
Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 |
g-MSH |
TYM040-010 |
Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly |
[Des-Ac] a-MSH, amide |
TYM034-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
[Dphe7] a-MSH, amide |
TYM035-010 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Dphe-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
| [Lys0] g-1-MSH, amide |
TYM042-010 |
Lys-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 |
|
|
|
|
Product |
CAT# |
Sequence |
Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe |
TYG023-010 |
Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe |
| Ile-Met-Gln-Val-Pro-Phe-Ser-Val |
TYI001-010 |
Ile-Met-Gln-Val-Pro-Phe-Ser-Val |
| Ile-Thr-Gln-Val-Pro-Phe-Ser-Val |
TYI002-010
TYI002-050 |
Ile-Thr-Gln-Val-Pro-Phe-Ser-Val |
| Mage-1 (161-169), human |
TYM005-010 |
Glu-Ala-Asp-Pro-Thr-Gly-His-Ser-Tyr |
Melanoma Associated Antigen 3 (167-176) [MAGE-3 Antigen
(167-176)], human |
TYM019-010 |
Met-Glu-Val-Asp-Pro-Ile-Gly-His-Leu-Tyr |
| Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp |
TYS017-010 |
Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp |
| Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp |
TYT015-010 |
Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp |
| [MAGE-3 Antigen (271-279)], human |
TYM006-010 |
Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val |
|
|
|
|
Product |
CAT# |
Sequence |
Neurokinin A (4-10) |
TYN015-010 |
Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
Neurokinin A / Substance K |
TYN016-010 |
His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
Neurokinin B |
TYN017-005
TYN017-010 |
Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 |
Neuromedin (U-25), porcine |
TYN018-005
TYN018-010 |
Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuromedin (U-8), porcine |
TYN019-010 |
Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuromedin B |
TYN020-010 |
Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 |
Neuromedin C |
TYN021-010 |
Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
Neuromedin U, rat |
TYN023-005
TYN023-010 |
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
[Tyr0] Neurokinin B |
TYN026-005 |
Tyr-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 |
|
|
|
|
Product |
CAT# |
Sequence |
Neurotensin (8-13) |
TYN032-010 |
Arg-Arg-Pro-Tyr-Ile-Leu |
Neurotensin (8-13), N-Acetyl |
TYN033-010 |
Ac-Arg-Arg-Pro-Tyr-Ile-Leu |
[Lys8,Asn9] Neurotensin LANT-6 (8-13) |
TYN037-010 |
Lys-Asn-Pro-Tyr-Ile-Leu |
[Trp11] Neurotensin (8-13) |
TYN038-010 |
Arg-Arg-Pro-Trp-Ile-Leu |
|
|
Parathyroid Hormone & Anologs(PTH) |
|
Product |
CAT# |
Sequence |
Parathyroid Hormone (13-34), human |
TYP014-005
TYP014-010 |
Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe |
Parathyroid Hormone (28-48), human |
TYP015-005
TYP015-010 |
Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly Ser |
Parathyroid Hormone (44-68), human |
TYP016-005
TYP016-010 |
Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly |
Parathyroid Hormone (69-84), human |
TYP017-005
TYP017-010 |
Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln |
| [Tyr27] PTH (27-48), human |
TYP071-005
TYP071-010 |
Tyr-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser |
| [Tyr43] PTH (43-68), human |
TYP072-005
TYP072-010 |
Tyr-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly |
| [Tyr63] PTH (63-84), human |
TYP073-010 |
Tyr-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln |
|
|
Signal Transduction Reagents |
|
Product |
CAT# |
Sequence |
Phosphate Acceptor Peptide |
TYP028-010
TYP028-050 |
Arg-Arg-Lys-Ala-Ser-Gly-Pro-Pro-Val |
PKC (19-35) Peptide |
TYP033-005
TYP033-010 |
Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys |
PKC (19-36) Peptide |
TYP034-005
TYP034-010 |
Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn |
Protein Kinase A Inhibitor Fragment (6-22), amide |
TYP062-005
TYP062-010 |
Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 |
Protein Kinase C (660-673) |
TYP063-005
TYP063-010 |
Ser-Phe-Val-Asn-Ser-Glu-Phe-Leu-Lys-Pro-Glu-Val-Lys-Ser |
Protein Kinase C (661-671) |
TYP064-005
TYP064-010 |
Ser-Tyr-Thr-Asn-Pro-Glu-Phe-Val-Ile-Asn-Val |
Protein Kinase C Substrate |
TYP068-010
TYP068-050 |
Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu |
| QKRPSQRSKYL |
TYQ001-005
TYQ001-010 |
Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu |
| RR-SRC |
TYR017-005
TYR017-010 |
Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly |
|
|
|
|
Product |
CAT# |
Sequence |
Substance P |
TYS035-050 |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
Substance P (1-7) |
TYS037-010 |
Arg-Pro-Lys-Pro-Gln-Gln-Phe |
Substance P (1-9) |
TYS038-010 |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly |
Substance P (2-11) /Deca-Substance P |
TYS039-010 |
Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
Substance P (3-11) /Nona-Substance P |
TYS040-010 |
Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
Substance P (4-11) /Octa-Substance P |
TYS041-010 |
Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
Substance P (5-11) /Hepta-Substance P |
TYS042-010 |
Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
Substance P (6-11) /Hexa-Substance P |
TYS043-010 |
Gln-Phe-Phe-Gly-Leu-Met-NH2 |
Substance P, Free Acid |
TYS046-050 |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met |
| Substance P-Gly-Lys-Arg |
TYS047-010 |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg |
| [Arg3] Substance P |
TYS048-010 |
Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| [Pro9] Substance P |
TYS055-005
TYS055-010 |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2 |
| [Tyr8] Substance P |
TYS058-010 |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2 |
|
|